Ascendis Pharma A/S
San Francisco · 1 people tracked
Investment thesis
Ascendis Pharma is a biopharmaceutical company that uses its TransCon technology platform to develop therapies in endocrinology rare disease and oncology. Headquartered in Denmark with research facilities in Germany and offices in Europe and the United States, it also partners with other companies to apply its platform in additional therapeutic areas.
Team · 1 people
from the firm's websiteFrequently asked questions
- What sectors does Ascendis Pharma A/S focus on?
- Ascendis Pharma A/S focuses on Biotech.
- Where is Ascendis Pharma A/S located?
- Ascendis Pharma A/S is headquartered in San Francisco, US.
Images
Similar investors
8VC is a technology investment firm that builds and invests in ambitious companies across sectors including life sciences, healthcare, manufacturing, enterprise, logistics, and defense.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Andreessen Horowitz's Strategic Partnerships page describes collaborations that connect its portfolio companies with established institutions to help scale and deploy their technology.
B Capital Group is a multi-stage venture capital firm that backs founders across the company-building lifecycle, investing in technology, healthcare, and energy & resilience sectors.